Introduction The rapid adoption of GLP-1 weight-loss medications such as Ozempic, Wegovy, and Mounjaro is reshaping consumer eating behavior these drugs are increasingly used not only for diabetes management but also for appetite and weight control, influencing how people select, consume, and prioritize food
The trial included 3,297 patients with type 2 diabetes and a high cardiovascular risk, who were randomized to receive either semaglutide (0.5 mg or 1.0 mg) subcutaneously once weekly or placebo
Healthcare providers may recommend baseline glucose tolerance testing or hemoglobin A1C measurement before conception to identify whether gestational diabetes risk is elevated, allowing for closer monitoring during pregnancy
The leader is Mounjaro (tirzepatide), produced by the American company Eli Lilly, which grossed R$ 8.5 billion during the period
The substitutions within the cyclic peptide further contribute to potency and stability
Q: How does WEGOVY 1MG INJECTION work in the body